Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's Thyroiditis

Hashimoto's thyroiditis is an inflammatory disease of the thyroid gland with autoimmune etiology.1 Patients afflicted with Hashimoto's have a higher risk of thyroid malignancies such as papillary thyroid carcinoma.2 In the present study, we investigated the frequency of papillary thyroid c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 1997-01, Vol.107 (1), p.95-100
Hauptverfasser: Wirtschafter, Ari, Schmidt, Richard, Rosen, David, Kundu, Nandita, Santoro, Massimo, Fusco, Alfredo, Multhaupt, Hinke, Atkins, Joseph P., Rosen, Marc R., Keane, William M., Rothstein, Jay L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hashimoto's thyroiditis is an inflammatory disease of the thyroid gland with autoimmune etiology.1 Patients afflicted with Hashimoto's have a higher risk of thyroid malignancies such as papillary thyroid carcinoma.2 In the present study, we investigated the frequency of papillary thyroid carcinoma specific genes in patients diagnosed with Hashimoto's disease. The newly identified oncogenes RET/PTC1 and RET/PTC3 provide useful and specific markers of the early stages of papillary carcinoma as they are highly specific for malignant cells. Using a sensitive and specific reverse transcriptase‐polymerase chain reaction (RT‐PCR) assay, we found messenger RNA(mRNA) expression for the RET/PTC1 and RET/PTC3 oncogenes in 95% of the Hashimoto's patients studied. All Hashimoto's patients presenting without histopathologic evidence of papillary thyroid cancer showed molecular genetic evidence of cancer. These data suggest that multiple, independent occult tumors exist in these patiens at high frequency.
ISSN:0023-852X
1531-4995
DOI:10.1097/00005537-199701000-00019